Satyanarayana Ande

Satyanarayana Ande

Auto-generated profile, based on publicly available information

Satyanarayana Ande

Georgia Cancer Center, Augusta University, Augusta, Georgia

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2023 in Molecular Cancer Research
Verified
Journal Article
Closed access
PDF file
CXCaixia Xi
Caixia Xi
JPJunfeng Pang
Junfeng Pang
ABAmanda Barrett
Amanda Barrett
AHAnatolij Horuzsko
Anatolij Horuzsko
SASatyanarayana Ande
Satyanarayana Ande
XZXingguo Zhu
Xingguo Zhu
Correlations between the oxidative stress response and metabolic reprogramming have been observed during malignant tumor formation; however, the detailed mechanism remains elusive. The transcription factor Nrf2, a master regulator of the oxidative stress response, mediates metabolic reprogramming in multiple cancers. In a mouse model of hepatocellular carcinoma (HCC), through metabolic profiling, genome-wide gene expression, and chromatin structure analyses, we present new evidence showing that in addition to altering antioxidative stress response signaling, Nrf2 ablation impairs multiple metabolic pathways to reduce the generation of acetyl-CoA and suppress histone acetylation in tumors, but not in tumor-adjacent normal tissue. Nrf2 ablation and dysregulated histone acetylation impair transcription complex assembly on downstream target antioxidant and metabolic regulatory genes for expression regulation. Mechanistic studies indicate that the regulatory function of Nrf2 is low glucose dependent, the effect of which is demolished under energy refeeding. Together, our results implicate an unexpected effect of Nrf2 on acetyl-CoA generation, in addition to its classic antioxidative stress response regulatory activity, integrates metabolic and epigenetic programs to drive HCC progression. Implications: This study highlights that Nrf2 integrates metabolic and epigenetic regulatory networks to dictate tumor progression and that Nrf2 targeting is therapeutically exploitable in HCC treatment.

12 July 2023
Verified
Other
Open access
PDF file
CXCaixia Xi
Caixia Xi
JPJunfeng Pang
Junfeng Pang
ABAmanda Barrett
Amanda Barrett
AHAnatolij Horuzsko
Anatolij Horuzsko
SASatyanarayana Ande
Satyanarayana Ande
XZXingguo Zhu
Xingguo Zhu
S9. MYC silencing reduced the expression of glycolysis genes in HepG2 cells.



12 July 2023
Verified
Other
Open access
PDF file
CXCaixia Xi
Caixia Xi
JPJunfeng Pang
Junfeng Pang
ABAmanda Barrett
Amanda Barrett
AHAnatolij Horuzsko
Anatolij Horuzsko
SASatyanarayana Ande
Satyanarayana Ande
XZXingguo Zhu
Xingguo Zhu
S2. Nrf2 ablation affects gene expression in mouse liver tumors.